Covishield Blood Clot Risk Minuscule but Govt Not Transparent, Need Urgent Inquiry—Gagandeep Kang
- 3 years ago
Note: The symptoms of a post-vaccination blood clot that Dr Gagandeep Kang describes at 31'10'' are very rare but watch out for them between 4 and 20 days of your jab
In a 35 minute interview to Karan Thapar for The Wire, Dr Gagandeep Kang, considered to be one of India’s top vaccine scientists, said that in India we simply don't have any official information whether there have been worrying blood clots with a low platelet count after taking the Covishield vaccine. AstraZeneca's shot is called Covishield in India. In the last few weeks, reports of rare forms of blood clots showing up in a small number of this vaccine's recipients in Europe had sent alarm bells ringing among national regulators in various countries. Dr Kang said that these conditions are marked by blood clots in veins in the brain and abdomen accompanied by low platelet counts. She also said that hospitals would no doubt have this information but didn't know if it had reached the government's adverse events committee or, if it had, what the committee has done with the data. The committee and the government have simply not said anything at all, and the government stopped sharing any details of potential vaccine-related side effects in India after February 26. There is no transparency at all regarding this matter. Later in the interview, she also said the government “is trying to do it’s best.”
Like our work? Click here to support The Wire: https://thewire.in/support
The founding premise of The Wire is this: if good journalism is to survive and thrive, it can only do so by being both editorially and financially independent. This means relying principally on contributions from readers and concerned citizens who have no interest other than to sustain a space for quality journalism. As a publication, The Wire will be firmly committed to the public interest and democratic values.
We publish in four different languages!
For English, visit www.thewire.in
for Hindi: http://thewirehindi.com/
for Urdu: http://thewireurdu.com
for Marathi: https://marathi.thewire.in
If you are a young writer or a creator, you can submit articles, essays, photos, poetry – anything that’s straight out of your imagination – to LiveWire, The Wire’s portal for the young, by the young. https://livewire.thewire.in/
You can also follow The Wire’s social media platforms and engage with us.
Facebook
https://www.facebook.com/TheWire/
https://www.facebook.com/TheWireHindi/
https://www.facebook.com/TheWireUrdu/
https://www.facebook.com/TheWireMarathi/
Twitter
https://twitter.com/thewire_in
https://twitter.com/thewirehindi
https://twitter.com/TheWireUrdu
https://twitter.com/TheWireMarathi
https://twitter.com/livewire
Instagram
https://www.instagram.com/thewirein/
https://www.instagram.com/livewirein/
Don’t forget to hit the subscribe button to never miss a video from The Wire!
In a 35 minute interview to Karan Thapar for The Wire, Dr Gagandeep Kang, considered to be one of India’s top vaccine scientists, said that in India we simply don't have any official information whether there have been worrying blood clots with a low platelet count after taking the Covishield vaccine. AstraZeneca's shot is called Covishield in India. In the last few weeks, reports of rare forms of blood clots showing up in a small number of this vaccine's recipients in Europe had sent alarm bells ringing among national regulators in various countries. Dr Kang said that these conditions are marked by blood clots in veins in the brain and abdomen accompanied by low platelet counts. She also said that hospitals would no doubt have this information but didn't know if it had reached the government's adverse events committee or, if it had, what the committee has done with the data. The committee and the government have simply not said anything at all, and the government stopped sharing any details of potential vaccine-related side effects in India after February 26. There is no transparency at all regarding this matter. Later in the interview, she also said the government “is trying to do it’s best.”
Like our work? Click here to support The Wire: https://thewire.in/support
The founding premise of The Wire is this: if good journalism is to survive and thrive, it can only do so by being both editorially and financially independent. This means relying principally on contributions from readers and concerned citizens who have no interest other than to sustain a space for quality journalism. As a publication, The Wire will be firmly committed to the public interest and democratic values.
We publish in four different languages!
For English, visit www.thewire.in
for Hindi: http://thewirehindi.com/
for Urdu: http://thewireurdu.com
for Marathi: https://marathi.thewire.in
If you are a young writer or a creator, you can submit articles, essays, photos, poetry – anything that’s straight out of your imagination – to LiveWire, The Wire’s portal for the young, by the young. https://livewire.thewire.in/
You can also follow The Wire’s social media platforms and engage with us.
https://www.facebook.com/TheWire/
https://www.facebook.com/TheWireHindi/
https://www.facebook.com/TheWireUrdu/
https://www.facebook.com/TheWireMarathi/
https://twitter.com/thewire_in
https://twitter.com/thewirehindi
https://twitter.com/TheWireUrdu
https://twitter.com/TheWireMarathi
https://twitter.com/livewire
https://www.instagram.com/thewirein/
https://www.instagram.com/livewirein/
Don’t forget to hit the subscribe button to never miss a video from The Wire!